These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 19552723)

  • 1. Drug cross-resistance and therapy-induced resistance in chronic lymphocytic leukaemia by an enhanced method of individualised tumour response testing.
    Bosanquet AG; Richards SM; Wade R; Else M; Matutes E; Dyer MJ; Rassam SM; Durant J; Scadding SM; Raper SL; Dearden CE; Catovsky D
    Br J Haematol; 2009 Aug; 146(4):384-95. PubMed ID: 19552723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical effectiveness and cost-effectiveness results from the randomised, Phase IIB trial in previously untreated patients with chronic lymphocytic leukaemia to compare fludarabine, cyclophosphamide and rituximab with fludarabine, cyclophosphamide, mitoxantrone and low-dose rituximab: the Attenuated dose Rituximab with ChemoTherapy In Chronic lymphocytic leukaemia (ARCTIC) trial.
    Howard DR; Munir T; McParland L; Rawstron AC; Chalmers A; Gregory WM; O'Dwyer JL; Smith A; Longo R; Varghese A; Smith A; Hillmen P
    Health Technol Assess; 2017 May; 21(28):1-374. PubMed ID: 28628003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bax expression correlates with cellular drug sensitivity to doxorubicin, cyclophosphamide and chlorambucil but not fludarabine, cladribine or corticosteroids in B cell chronic lymphocytic leukemia.
    Bosanquet AG; Sturm I; Wieder T; Essmann F; Bosanquet MI; Head DJ; Dörken B; Daniel PT
    Leukemia; 2002 Jun; 16(6):1035-44. PubMed ID: 12040435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ex vivo assessment of drug response by differential staining cytotoxicity (DiSC) assay suggests a biological basis for equality of chemotherapy irrespective of age for patients with chronic lymphocytic leukaemia.
    Bosanquet AG; Bosanquet MI
    Leukemia; 2000 Apr; 14(4):712-5. PubMed ID: 10764159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel ex vivo analysis of nonclassical, pleiotropic drug resistance and collateral sensitivity induced by therapy provides a rationale for treatment strategies in chronic lymphocytic leukemia.
    Bosanquet AG; Bell PB
    Blood; 1996 Mar; 87(5):1962-71. PubMed ID: 8634445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pentostatin (Nipent) and chlorambucil with granulocyte-macrophage colony-stimulating factor support for patients with previously untreated, treated, and fludarabine-refractory B-cell chronic lymphocytic leukemia.
    Waselenko JK; Grever MR; Beer M; Lucas MA; Byrd JC
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):44-51. PubMed ID: 10877052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognosis for fludarabine therapy of chronic lymphocytic leukaemia based on ex vivo drug response by DiSC assay.
    Bosanquet AG; Johnson SA; Richards SM
    Br J Haematol; 1999 Jul; 106(1):71-7. PubMed ID: 10444165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced ex vivo drug sensitivity testing of chronic lymphocytic leukaemia using refined DiSC assay methodology.
    Bosanquet AG; Bell PB
    Leuk Res; 1996 Feb; 20(2):143-53. PubMed ID: 8628013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia. The French Cooperative Group on CLL.
    Johnson S; Smith AG; Löffler H; Osby E; Juliusson G; Emmerich B; Wyld PJ; Hiddemann W
    Lancet; 1996 May; 347(9013):1432-8. PubMed ID: 8676625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rituximab plus fludarabine and cyclophosphamide or other agents in chronic lymphocytic leukemia.
    Robak T; Lech-Maranda E; Robak P
    Expert Rev Anticancer Ther; 2010 Oct; 10(10):1529-43. PubMed ID: 20942624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purine analogs in chronic lymphocytic leukemia and Waldenström's macroglobulinemia.
    O'Brien S; Kantarjian H; Keating MJ
    Ann Oncol; 1996; 7 Suppl 6():S27-33. PubMed ID: 9010576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro chemosensitivity of chronic lymphocytic leukaemia to purine analogues--correlation with clinical course.
    Bromidge TJ; Turner DL; Howe DJ; Johnson SA; Rule SA
    Leukemia; 1998 Aug; 12(8):1230-5. PubMed ID: 9697877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemosensitivity of lymphocytes from patients with B-cell chronic lymphocytic leukemia to chlorambucil, fludarabine, and camptothecin analogs.
    Silber R; Degar B; Costin D; Newcomb EW; Mani M; Rosenberg CR; Morse L; Drygas JC; Canellakis ZN; Potmesil M
    Blood; 1994 Nov; 84(10):3440-6. PubMed ID: 7949099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro evaluation of fludarabine in combination with cyclophosphamide and/or mitoxantrone in B-cell chronic lymphocytic leukemia.
    Bellosillo B; Villamor N; Colomer D; Pons G; Montserrat E; Gil J
    Blood; 1999 Oct; 94(8):2836-43. PubMed ID: 10515887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The in vitro cytotoxic effect of mitoxantrone in combination with fludarabine or pentostatin in B-cell chronic lymphocytic leukemia.
    Morabito F; Callea I; Console G; Stelitano C; Sculli G; Filangeri M; Oliva B; Musolino C; Iacopino P; Brugiatelli M
    Haematologica; 1997; 82(5):560-5. PubMed ID: 9407721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy of chronic lymphocytic leukaemia with purine nucleoside analogues: facts and controversies.
    Robak T
    Drugs Aging; 2005; 22(12):983-1012. PubMed ID: 16363884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylprednisolone in advanced chronic lymphocytic leukaemia: rationale for, and effectiveness of treatment suggested by DiSC assay.
    Bosanquet AG; McCann SR; Crotty GM; Mills MJ; Catovsky D
    Acta Haematol; 1995; 93(2-4):73-9. PubMed ID: 7543720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flavopiridol circumvents Bcl-2 family mediated inhibition of apoptosis and drug resistance in B-cell chronic lymphocytic leukaemia.
    Pepper C; Thomas A; Hoy T; Fegan C; Bentley P
    Br J Haematol; 2001 Jul; 114(1):70-7. PubMed ID: 11472347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current and emerging treatments for chronic lymphocytic leukaemia.
    Robak T; Jamroziak K; Robak P
    Drugs; 2009; 69(17):2415-49. PubMed ID: 19911856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug resistance mechanisms in chronic lymphocytic leukemia.
    Ribrag V; Massade L; Faussat AM; Dreyfus F; Bayle C; Gouyette A; Marie JP
    Leukemia; 1996 Dec; 10(12):1944-9. PubMed ID: 8946935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.